UB Paderborn / Katalog / Suche / in CDI

Es ist ein Fehler in der Kommunikation mit einem externen System aufgetreten. Bitte versuchen Sie Ihre letzte Aktion erneut. Sollte der Fehler bestehen bleiben, setzen Sie sich bitte mit dem Informationszentrum der Bibliothek in Verbindung oder versuchen Sie es später erneut.

1 – 25 von 48

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

Annals of oncology, 2007-02, Vol.18 (2), p.317-323

2007

Volltextzugriff (PDF)

Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer

British journal of cancer, 2003-02, Vol.88 (3), p.335-341

2003

Volltextzugriff (PDF)

Phase I–II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer

Annals of oncology, 2005-03, Vol.16 (3), p.430-436

2005

Volltextzugriff (PDF)

Predictive Factors for Interstitial Lung Disease, Antitumor Response, and Survival in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

Journal of clinical oncology, 2006-06, Vol.24 (16), p.2549-2556

2006

Volltextzugriff (PDF)

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer

Journal of clinical oncology, 1992-01, Vol.10 (1), p.16-20

1992

Volltextzugriff (PDF)

Randomised phase II study of docetaxel/cisplatin vs docetaxel/ irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803)

British journal of cancer, 2004-01, Vol.90 (1), p.87-92

2004

Volltextzugriff (PDF)

Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer

Journal of clinical oncology, 1999-09, Vol.17 (9), p.2692-2699

1999

Volltextzugriff (PDF)

Irinotecan and etoposide for previously untreated extensive-disease small cell lung cancer: A phase II trial of West Japan Thoracic Oncology Group

Lung cancer (Amsterdam, Netherlands), 2005-08, Vol.49 (2), p.263-269

2005

Volltextzugriff (PDF)

Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer

International journal of clinical oncology, 2001-12, Vol.6 (6), p.296-301

2001

Volltextzugriff (PDF)

Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: Long-term follow-up results. Japan Clinical Oncology Group Protocol 8902

Annals of oncology, 2000-04, Vol.11 (4), p.445-450

2000

Volltextzugriff (PDF)

Post-marketing surveillance (PMS) of all patients treated with irinotecan in Japan: clinical experience and ADR profile of 13,935 patients

Japanese journal of clinical oncology, 2011-09, Vol.41 (9), p.1101-1111

2011

Volltextzugriff (PDF)

Phase I/II study of amrubicin, a novel 9-aminoanthracycline, in patients with advanced non-small-cell lung cancer

Investigational new drugs, 2005-08, Vol.23 (4), p.331-337

2005

Volltextzugriff (PDF)

Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial

Investigational new drugs, 2006-03, Vol.24 (2), p.151-158

2006

Volltextzugriff (PDF)

Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group

Journal of clinical oncology, 1998-06, Vol.16 (6), p.2126-2132

1998

Volltextzugriff (PDF)

Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group

Journal of clinical oncology, 1998-03, Vol.16 (3), p.1068-1074

1998

Volltextzugriff (PDF)

Phase I clinical trial of RP 56976 (docetaxel) a new anticancer drug

Gan to kagaku ryoho, 1994-09, Vol.21 (12), p.1997

1994

Volltextzugriff (PDF)

Progress of treatment on lung cancer--US-Japan joint seminar

Gan to kagaku ryoho, 1995-07, Vol.22 (8), p.1119

1995

Volltextzugriff (PDF)

New promising anticancer drugs for lung cancer

Gan to kagaku ryoho, 1994-11, Vol.21 (15), p.2578

1994

Volltextzugriff (PDF)

Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis

Gan to kagaku ryoho, 1997-06, Vol.24 (8), p.995

1997

Volltextzugriff (PDF)

DNA topoisomerase inhibitor

Gan to kagaku ryoho, 1992-11, Vol.19 (13), p.2140

1992

Volltextzugriff (PDF)

Pilot study of dose intensive weekly chemotherapy followed by cisplatin plus etoposide with concurrent thoracic irradiation for limited-disease small-cell lung cancer. West Japan Thoracic Oncology Group

Gan to kagaku ryoho, 2000-07, Vol.27 (8), p.1091

2000

Volltextzugriff (PDF)

Phase I study on DMDC

Gan to kagaku ryoho, 1996-11, Vol.23 (13), p.1799

1996

Volltextzugriff (PDF)

Phase I study of a new platinum complex 254-S, cis-diammine (glycolato)-platinum (II)

Gan to kagaku ryoho, 1992-06, Vol.19 (6), p.855

1992

Volltextzugriff (PDF)

A phase II clinical study of cis-diammine glycolato platinum, 254-S, for primary lung cancer

Gan to kagaku ryoho, 1992-06, Vol.19 (6), p.879

1992

Volltextzugriff (PDF)

Phase-I clinical study of KW-2307 combined with cisplatin in non-small cell lung cancer patients

Gan to kagaku ryoho, 1994-06, Vol.21 (7), p.993

1994

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Aktive Filter

ThemaLung Neoplasms - Drug Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(48)

Sprache

Englisch
(25)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

Humans
(48)
Female
(41)
Male
(40)
Middle Aged
(38)
Aged
(35)
Adult
(30)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(21)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(20)
Carcinoma, Small Cell - Drug Therapy
(18)
Life Sciences & Biomedicine
(18)
Oncology
(18)
Science & Technology
(18)
Drug Administration Schedule
(16)
Cisplatin - Administration & Dosage
(15)
Infusions, Intravenous
(14)
Biological And Medical Sciences
(11)
Cisplatin - Adverse Effects
(11)
Medical Sciences
(11)
Camptothecin - Analogs & Derivatives
(10)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer

Phase I–II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer

Predictive Factors for Interstitial Lung Disease, Antitumor Response, and Survival in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer

Randomised phase II study of docetaxel/cisplatin vs docetaxel/ irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803)

Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer

Irinotecan and etoposide for previously untreated extensive-disease small cell lung cancer: A phase II trial of West Japan Thoracic Oncology Group

Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer

Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: Long-term follow-up results. Japan Clinical Oncology Group Protocol 8902

Post-marketing surveillance (PMS) of all patients treated with irinotecan in Japan: clinical experience and ADR profile of 13,935 patients

Phase I/II study of amrubicin, a novel 9-aminoanthracycline, in patients with advanced non-small-cell lung cancer

Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial

Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group

Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group

Phase I clinical trial of RP 56976 (docetaxel) a new anticancer drug

Progress of treatment on lung cancer--US-Japan joint seminar

New promising anticancer drugs for lung cancer

Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis

DNA topoisomerase inhibitor

Pilot study of dose intensive weekly chemotherapy followed by cisplatin plus etoposide with concurrent thoracic irradiation for limited-disease small-cell lung cancer. West Japan Thoracic Oncology Group

Phase I study on DMDC

Phase I study of a new platinum complex 254-S, cis-diammine (glycolato)-platinum (II)

A phase II clinical study of cis-diammine glycolato platinum, 254-S, for primary lung cancer

Phase-I clinical study of KW-2307 combined with cisplatin in non-small cell lung cancer patients

Aktive Filter

Suchergebnisse filtern